Glucocorticoid Replacement and Cardiovascular Management in Addison’s Disease with Coronary Artery Disease

Glucocorticoid Replacement Optimization

Short‑acting hydrocortisone (or cortisone acetate) is the preferred glucocorticoid for adrenal‑insufficiency replacement because it is associated with fewer adverse cardiovascular effects than long‑acting agents such as prednisone. 1
In adults, the recommended hydrocortisone regimen is 15–25 mg per day divided into 2–3 doses, with the first dose taken upon awakening (before 9 am) and the final dose 4–6 hours before bedtime. 1, 2
Dose conversion between agents should use the equivalence 20 mg hydrocortisone ≈ 5 mg prednisone when switching therapies. 3
Signs of glucocorticoid excess (e.g., weight gain, central adiposity, hypertension, hyperglycemia, insomnia, peripheral edema) warrant dose reduction to the lowest amount that maintains adequate clinical response. 1, 2
Adequacy of replacement should be judged by clinical assessment rather than relying solely on a single morning cortisol measurement. 2

Statin therapy is recommended for all patients with chronic coronary syndromes, including those with Addison’s disease. 4, 5, 6
Low‑dose aspirin (75–100 mg daily) is advised for patients with established CAD. 5, 6, 7
Angiotensin‑converting‑enzyme inhibitors or angiotensin‑II receptor blockers should be used in CAD patients who have hypertension, diabetes, heart failure, or are considered high‑risk. 5, 6, 7
First‑line anti‑anginal therapy consists of beta‑blockers or calcium‑channel blockers. 4, 5, 6
Proton‑pump inhibitor prophylaxis is indicated for patients receiving aspirin monotherapy or dual antiplatelet therapy who are at high risk of gastrointestinal bleeding. 5, 6, 7
Annual evaluation of lipid profile, glucose metabolism, and renal function is recommended for all patients with stable CAD. 8

At each clinical encounter, assess cardiovascular risk factors—including blood pressure, lipid levels, and glycemic control. 4, 5
Provide comprehensive patient education on stress‑dosing for sick days, use of emergency injectable glucocorticoids, and recognition of adrenal‑crisis symptoms. 3, 2
Advise patients to wear a medical‑alert bracelet or necklace indicating adrenal insufficiency. 3, 2
Ensure an endocrinology consultation is obtained before any surgical or high‑stress cardiac intervention to optimize glucocorticoid management. 3